Google
×
Nov 24, 2021 · The novel biomarker soluble suppression of tumorigenicity 2 (sST-2) shows promising results for risk stratification in cardiovascular patients.
The pT356/pT359-SST2 Phosphorylation Assay Kit allows determination of SST2 Phosphorylation in 96-well plates without the need for Western blot analysis. $ ...
Mar 13, 2020 · Conclusions. Soluble suppression of tumorigenicity 2‐guided therapy over a short period of time does not reduce readmissions. However, sST2 was ...
Oct 21, 2019 · Laboratory diagnostics plays a major role in the diagnosis, risk stratification, therapy decision-making, and monitoring of patients with heart ...
Jan 30, 2024 · Soluble suppression of tumorigenicity 2 (sST2) is a serum biomarker for fibrotic processes. The aim of this study was to evaluate sST2 as marker ...
May 1, 2021 · This review will focus on recent studies from our and other groups that have investigated the trafficking and signaling of SST2 in Pan-NETs, in ...
Jun 7, 2013 · Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.
$350.00
The SST2 receptor antibody is directed against the distal end of the carboxyl-terminal tail of mouse, rat and human Somatostatin Receptor 2.
Jun 24, 2021 · The predictive role of sST2 in HF is somewhat limited in some situations. A study investigating cardiac resynchronization therapy (CRT) and ...
May 8, 2023 · Background: Somatostatin receptor type 2 (SST2) expression is critical for the diagnosis and treatment of neuroendocrine tumors and is ...
Luxurious spa services in Leesburg. Relax at the award-winning Woodhouse Spa. Book today. Experience top-tier pampering at Leesburg's Woodhouse Spa – It's like a mini vacation. LED Light Therapy. Signature Mood Treatments.